Skip to main navigation
Treatments for the Advancement of Life
  Menu
  • Home
  • About Us
    • Company Profile
    • Board of Directors
    • Management
    • Contact Us
  • Pipeline
    • Azeliragon
    • TTP399
    • TTP273
    • HPP593
    • HPP737
    • Nrf2/Bach1 Program
    • Expanded Access
  • Technology
  • News
    • Press Releases
    • Publications
  • Investors

    Investor Relations

    • Investor Overview
    • Stock Information
    • Financial Information
    • News & Events
    • Corporate Governance
    • Shareholder Services

Investor Relations

  • Investor Overview
  • Stock Information
  • Financial Information
  • News & Events
  • Corporate Governance
  • Shareholder Services

Shareholder Tools

  • Print Page
  • RSS Feeds
  • Share Page
  • E-mail Alerts
  • IR Contacts
X
  • Share on:
  • E-mail
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Reddit
  • Digg
  • Google
  • Delicious
  • StumbleUpon

SEC Filing Details

Document Details

Form
10-K
Filing Date
Feb 24, 2017
Document Date
Dec 31, 2016
Form Description
Annual report which provides a comprehensive overview of the company for the past year
Filing Group
Annual Filings
Company
vTv Therapeutics Inc.
Issuer
vTv Therapeutics Inc.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.INS - XBRL INSTANCE DOCUMENT
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.CAL - XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE
EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE

Information

  • Pipeline
  • Management

Location

  • Contact Us

About vTv

  • About Company

(c) Copyright 2019 VTV Therapeutics. Designed by vTv Therapeutics.